Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
180 Life Sciences Corp
(NQ:
ATNF
)
1.640
-0.190 (-10.38%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about 180 Life Sciences Corp
< Previous
1
2
3
Next >
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Initiates Formal Discussions with UK and US Regulatory Authorities Following Promising Dupuytren’s Trial
May 31, 2022
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Report Positive Results of Dupuytren’s Disease Study
May 02, 2022
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Scientific Advisory Board
February 17, 2022
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Shareholders from CEO Dr. James Woody
January 31, 2022
Via
Investor Brand Network
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Participation in Biotech Showcase 2022 Virtual Conference
December 28, 2021
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces License Agreement with University of Oxford
December 15, 2021
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Additional Info Regarding Successful Dupuytren Phase 2b Clinical Trial Results
December 06, 2021
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Receives Grants of New Patents Through Licensing Agreement
November 22, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Co-Founder to Keynote at 2021 International Dupuytren Symposium
November 18, 2021
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Strategic Appointment of Quan A. Vu
November 03, 2021
Via
Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Preclinical Report on the CBG Impact on Pain, Inflammation, Obesity
October 26, 2021
Via
Investor Brand Network
Topics
Cannabis
Derivatives
Exposures
Cannabis
Derivatives
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Continues to Expand Portfolio, Pipeline and Patient Access to Innovative Therapies
September 30, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF), Celltrion Healthcare Enter MOU for Strategic Supply Agreement
September 20, 2021
Via
Investor Brand Network
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.